Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec;82(Pt A):1-8.
doi: 10.1016/j.jocn.2020.10.005. Epub 2020 Nov 1.

Adult diffuse midline gliomas: Clinical, radiological, and genetic characteristics

Antonio Dono  1 , Takeshi Takayasu  1 , Leomar Y Ballester  2 , Yoshua Esquenazi  3
Affiliations

Adult diffuse midline gliomas: Clinical, radiological, and genetic characteristics

Antonio Dono et al. J Clin Neurosci. 2020 Dec.

Abstract

Diffuse midline gliomas (DMGs) are a diffuse glioma subtype arising from midline brain structures. It is predominantly a disease of childhood; however, it can also occur in adults. Adult DMG has not been previously well described. The aim of this study was to define the characteristics of adult DMG. We described and analyzed the clinical, radiological, and genetic alterations of 9 adult DMGs and compared them with those of 257 non-midline adult high-grade IDH-WT gliomas. The median age of all patients was 38-years old (23-68-years). Most common symptoms were headache, motor/sensory deficit, ataxia, cranial nerve deficit, and confusion. Tumor locations were brainstem (44.5%), thalamus (22.2%), pineal region (22.2%), spinal cord (22.2%), and cerebellum (11.1%). Six-patients (66.7%) were H3 K27M-WT and three (33.3%) were H3 K27M-mutant. In addition to H3 K27M mutations, TP53 gene (55.5%), CDKN2A/B and TERTp (33.3%), PDGFRA (33.3%), PIK3CA, PTEN, KDR, NF1, and MYC (22.2%) were the most frequently mutated genes. Neither IDH1/IDH2 nor EGFR alterations were present. Compared to non-midline high-grade glioma, adult DMG patients were younger (38 vs 61 years, p < 0.001) and lacked EGFR-alterations (0/9 vs 123/257, p = 0.004). The median survival of DMG and non-midline high-grade gliomas was 19 and 18 months respectively (p = 0.964). Our data support that adult DMGs have different oncogenic drivers compared to non-midline high-grade gliomas. Regardless of H3 K27M mutation status, neither of the nine adult DMG cases demonstrated IDH1/IDH2 or EGFR alterations. Larger multi-institutional studies are needed to further characterize the biology of this rare type of diffuse glioma in adults.

Keywords: Adult diffuse midline glioma; Brainstem glioma; H3 K27M; H3F3A; Thalamic glioblastoma.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest

The authors have no duality or conflicts of interest to declare.

Figures

Figure 1.
Figure 1.. Adult Diffuse Midline Glioma H3 K27M wildtype MRI imaging.
Patient 1, pineal/posterior third ventricular region Glioblastoma IDH-WT (A. Axial T1-post contrast. B. Axial T2 FLAIR). Patient 3, focal enhancing left thalamic Glioblastoma IDH-WT (C. Axial T1-post contrast. D. Axial T2 FLAIR). Patient 5, focal enhancing, right thalamic Glioblastoma IDHWT (E. Axial T1-post contrast). Patient 6, non-enhancing pontine and cerebellar peduncle Glioblastoma IDH-WT (F. Axial T1-post contrast. G. Axial T2 FLAIR. H. Sagittal T1-post contrast).
Figure 2.
Figure 2.. Adult Diffuse Midline Glioma H3 K27M mutant MRI imaging.
Patient 7, lower thoracic spinal cord Diffuse Midline Glioma H3 K27M mutant (A. Axial T1-post contrast. B. Sagittal T2). Patient 9: upper thoracic spinal cord Diffuse Midline Glioma H3 K27M mutant (C. Sagittal T2) Patient 8, non-enhancing pontine Diffuse Midline Glioma H3 K27M mutant (D. Axial T1-post contrast. E. Axial T2 FLAIR).
Figure 3.
Figure 3.
Histologic diagnosis, location, and genetic alterations in patients with Adult Diffuse Midline Glioma
Figure 4.
Figure 4.
Kaplan Meier Survival Curves between adult Diffuse Midline Glioma and nonmidline high-grade glioma IDH/H3 WT (median 19-months vs 18-months, p=0.964)
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Solomon DA, Wood MD, Tihan T, Bollen AW, Gupta N, Phillips JJJ, et al. Diffuse Midline Gliomas with Histone H3-K27M Mutation: A Series of 47 Cases Assessing the Spectrum of Morphologic Variation and Associated Genetic Alterations. Brain Pathol 2016;26:569–80. 10.1111/bpa.12336. - DOI - PMC - PubMed
    1. Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol 2016;131:803–20. 10.1007/s00401-016-1545-1. - DOI - PubMed
    1. Ebrahimi A, Skardelly M, Schuhmann MU, Ebinger M, Reuss D, Neumann M, et al. High frequency of H3 K27M mutations in adult midline gliomas. J Cancer Res Clin Oncol 2019;145:839–50. 10.1007/s00432-018-02836-5. - DOI - PubMed
    1. Kleinschmidt-DeMasters BK, Levy JMM. H3 K27M-mutant gliomas in adults vs. children share similar histological features and adverse prognosis. Clin Neuropathol 2018;37:53–63. 10.5414/NP301085. - DOI - PMC - PubMed
    1. Jiang H, Yang K, Ren X, Cui Y, Li M, Lei Y, et al. Diffuse midline glioma with H3 K27M mutation: a comparison integrating the clinical, radiological, and molecular features between adult and pediatric patients. Neuro Oncol 2019:1–9. 10.1093/neuonc/noz152. - DOI - PMC - PubMed